SUBSCRIBE

Gantry 5
  • HOME
  • OUR FOCUS
      • Back
      • Obesity
      • Diabetes
  • OUR COMPANY
      • Back
      • Strategy
      • Leadership
  • THE SCIENCE
      • Back
      • Role of AMPK
      • Cancer
      • Alzheimer's Disease
      • Anti-Aging
  • THE PIPELINE
      • Back
      • Screening
      • Validation
  • INVESTORS & MEDIA
      • Back
      • Presentations
      • SEC Filings
      • Stock Info
      • XBRL Filings
      • News
          • Back
          • 2017 News
          • 2016 News
  • CONTACT
 

SITE MAP

Nexus BioPharma, Inc

  • HOME
  • OUR FOCUS
    • Obesity
    • Diabetes
  • OUR COMPANY
    • Strategy
    • Leadership
      • Warren C. Lau
      • Dr. Jeffrey Pessin
      • Dr. Daniel Einhorn
  • THE SCIENCE
    • Role of AMPK
    • Cancer
    • Alzheimer's Disease
    • Anti-Aging
  • THE PIPELINE
    • Screening
    • Validation
  • INVESTORS & MEDIA
    • Presentations
    • SEC Filings
    • Stock Info
    • News
      • Nexus BioPharma, Inc. Selected to Become a Resident Company at JLABS @ TMC
      • 2017 News
        • Nexus BioPharma, Inc. Selected to Become a Resident Company at JLABS @ TMC
      • 2016 News
        • Nexus BioPharma, Inc. Completes Merger
        • Nexus BioPharma , Inc. Appoints Jeffrey Pessin, Ph.D. as Chairman of Scientific Advisory Board
        • Nexus BioPharma, Inc. Appoints Daniel Einhorn, M.D. to Scientific & Clinical Advisory Board
        • Nexus BioPharma, Inc. Expands Intellectual Property Scope
        • Nexus BioPharma, Inc. Appoints Helen Stefanovic as Director of Regulatory Affairs
        • Nexus BioPharma, Inc. Provides Business Outlook and Sets Corporate Milestones
        • Nexus BioPharma Announces Agreement with TransChem for Kinase Inhibition Technology
  • CONTACT
  • ABOUT US
  • SITE MAP
  • SUBSCRIBE
  • uncategorised
    • test
    • About Us
  • NEXUS BIOPHARMA, INC © 2021
  • TERMS & CONDITIONS
  • SITE MAP
  • CONTACT US
  • RSS

Website powered by Sandman Media